In addition, brucine, strychine and triptolide significantly inhibited the expression of arthritis-related inflammatory factors (i.e., TNF-α, IL-6, COX-2, and iNOS) (Figures 7C, 8C). Here, IL6 is linked to arthritic joint disease.